| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/22/2011 | US7910316 Kit and method for detecting urothelial cancer |
| 03/22/2011 | US7910315 Early detection of hemangiosarcoma and angiosarcoma |
| 03/22/2011 | US7910314 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer |
| 03/22/2011 | US7910300 Disease detection by protein truncation assays |
| 03/22/2011 | US7910296 Using DNA methylation pattern of preferential genomic regions as tool in diagnosing cell proliferative disorders |
| 03/22/2011 | US7910295 Amplifying nucleic acid targets from panels containing markers such as antigens, binding proteins, and/or tyrosinase; reverse transcriptase-polymerase chain reaction (RT-PCR); kits |
| 03/22/2011 | US7910294 Based on the combination of a specific ligand/ receptor binding reaction and a detection step involving detection of a nucleic acid marker by amplification and real- time detection of the amplification products |
| 03/22/2011 | US7910293 Development of prognostic markers from the saliva of head and neck cancer patients |
| 03/22/2011 | US7910100 Antibodies directed to the mammalian EAG1 ion channel protein |
| 03/22/2011 | US7910099 Antibodies to VLA-1 |
| 03/22/2011 | US7910098 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation |
| 03/22/2011 | US7910097 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof |
| 03/22/2011 | US7910087 Generating light |
| 03/22/2011 | US7910063 Drift compensated magnetic permeability detector |
| 03/22/2011 | US7910061 Comprises a light source, a cuvette which contains a sample and is held on the optical axis of a measuring light beam during a measurement, a filter assembly on which a plurality of filters are arranged in a circular pattern |
| 03/22/2011 | US7910059 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 03/22/2011 | US7909984 Small volume in vitro analyte sensor |
| 03/22/2011 | US7909777 Method and apparatus for penetrating tissue |
| 03/22/2011 | US7909776 Lancets for bodily fluid sampling supplied on a tape |
| 03/22/2011 | US7909774 Method and apparatus for penetrating tissue |
| 03/22/2011 | US7908930 Systems and methods for measuring multiphase flow in a hydrocarbon transporting pipeline |
| 03/22/2011 | US7908900 Friction measuring device |
| 03/22/2011 | CA2648390C Downhole tool for measuring a fluid flow rate therethrough and a well completion incorporating same |
| 03/22/2011 | CA2546808C Device for a torque or shear force transmitter for the determination of fibre concentration or viscosity in pulp suspensions and method for resetting of the transmitter shaft in atorque or shear force transmitter |
| 03/22/2011 | CA2532467C Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization |
| 03/22/2011 | CA2510950C Cinnamic acid 4-hydroxylase |
| 03/22/2011 | CA2498228C Hcv assay |
| 03/22/2011 | CA2471769C Oral insulin therapy |
| 03/22/2011 | CA2464713C A peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis |
| 03/22/2011 | CA2454228C Radiolabeled neuropeptide y y5 receptor antagonists |
| 03/22/2011 | CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof |
| 03/22/2011 | CA2428999C Solid medium and method for producing the same |
| 03/22/2011 | CA2361590C Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes |
| 03/22/2011 | CA2240409C Mammalian cx3c chemokine genes |
| 03/22/2011 | CA2236159C Vp antigens of the jc virus |
| 03/22/2011 | CA2136958C Method for inhibition of viral morphogenesis |
| 03/21/2011 | CA2714323A1 Method for scanning the internal quality of wooden elements having a main direction of extension, such as logs or planks |
| 03/18/2011 | CA2737048A1 Sonication-assisted metal-enhanced fluorescence (samef)-based bioassays |
| 03/17/2011 | WO2011032155A2 Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury |
| 03/17/2011 | WO2011032125A2 Method for predicting reactivity of a hydrocarbon-containing feedstock for hydroprocessing |
| 03/17/2011 | WO2011032123A2 Method for determining asphaltene stability of a hydrocarbon-containing material |
| 03/17/2011 | WO2011032109A1 Biomarkers for spinal muscular atrophy |
| 03/17/2011 | WO2011032097A1 Methods for characterizing antibody binding affinity and epitope diversity in food allergy |
| 03/17/2011 | WO2011032088A1 Polymorphisms in the pde3a gene |
| 03/17/2011 | WO2011032078A1 Detection of x4 strains of hiv-1 by heteroduplex tracking assay |
| 03/17/2011 | WO2011032013A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer agent |
| 03/17/2011 | WO2011031986A1 Assays for soluble il-15 receptor alpha |
| 03/17/2011 | WO2011031944A1 Toll-like receptor 4 deficiency and downstream effectors cause pulmonary emphysema |
| 03/17/2011 | WO2011031892A1 Use of microvesicles in analyzing kras mutations |
| 03/17/2011 | WO2011031877A1 Use of microvesicles in analyzing nucleic acid profiles |
| 03/17/2011 | WO2011031833A2 Human anti-cancer antibodies |
| 03/17/2011 | WO2011031782A2 System and method for measuring conductivity/resistivity of water having high purity |
| 03/17/2011 | WO2011031751A1 Electrochemical test sensor |
| 03/17/2011 | WO2011031736A2 Methods of identifying anti-inflammatory compounds |
| 03/17/2011 | WO2011031562A1 Synthetic mycotoxin adsorbents and methods of making and utilizing the same |
| 03/17/2011 | WO2011031560A2 Materials and methods for the differential diagnosis of pancreatic lesions |
| 03/17/2011 | WO2011031517A1 Method and assay for determining fas expression |
| 03/17/2011 | WO2011031497A2 Quantitative fluorescent protein standards |
| 03/17/2011 | WO2011031493A2 Galectin-3 and cardiac resynchronization therapy |
| 03/17/2011 | WO2011031472A2 Detection of auto-antibodies to specific glycans as diagnostic tests for autoimmune diseases |
| 03/17/2011 | WO2011031438A2 Porcine torque teno virus vaccines and diagnosis |
| 03/17/2011 | WO2011031344A1 Cancer biomarkers and uses thereof |
| 03/17/2011 | WO2011031330A1 Autophagy and phospholipidosis pathway assays |
| 03/17/2011 | WO2011031025A2 Method for detecting and quantifying a target substance using a biochip |
| 03/17/2011 | WO2011030983A1 Portable digital reader for urinalysis |
| 03/17/2011 | WO2011030982A1 Portable digital reader for urinalysis |
| 03/17/2011 | WO2011030944A1 Method and device for dna sequence analysis using multiple pna |
| 03/17/2011 | WO2011030823A1 Carrier for holding nucleic acids |
| 03/17/2011 | WO2011030360A1 Machine for automatic detection of flaws on pieces made of leather or similar material |
| 03/17/2011 | WO2011030302A1 An isolated monophosphorylated peptide derived from human alpha-enolase useful for diagnosis and treatment of pancreatic adenocarcinoma, antibodies directed against the said monophosphorylated peptide, and uses thereof |
| 03/17/2011 | WO2011030300A1 Synthetic peptides from the sv40 t-antigen for use in an indirect elisa test for the identification of antibodies against simian virus 40 in human serum and other fluids |
| 03/17/2011 | WO2011030286A1 Highly sensitive immunoassay with large particle labels |
| 03/17/2011 | WO2011030243A1 Methods and apparatus for characterization of petroleum fluid employing analysis of high molecular weight components |
| 03/17/2011 | WO2011030217A2 Method for diagnosing multiple sclerosis |
| 03/17/2011 | WO2011030186A1 Identifying transition points in chemical reactions |
| 03/17/2011 | WO2011030168A1 Detection method based on time resolved real time fluorescent energy transfer (tr-fret) |
| 03/17/2011 | WO2011030159A1 Method using hla epitope determination |
| 03/17/2011 | WO2011030153A1 Biomarkers for schizophrenia or other psychotic disorders |
| 03/17/2011 | WO2011030108A1 Jmjd2 demethylase inhibitors |
| 03/17/2011 | WO2011030093A1 Glucose measurement method and system |
| 03/17/2011 | WO2011029996A1 Use of vap-1 inhibitors for treating fibrotic conditions |
| 03/17/2011 | WO2011029954A2 Polypeptide marker for diagnosing and assessing vascular diseases |
| 03/17/2011 | WO2011029946A1 A proteolytic product of histone h2a as a marker for cancer |
| 03/17/2011 | WO2011029939A1 Method for diagnosing and/or predicting the development of neurodegenerative diseases |
| 03/17/2011 | WO2011029889A1 Drug detection in exhaled breath |
| 03/17/2011 | WO2011029888A1 Surface-enhanced raman scattering for drug detection in exhaled breath |
| 03/17/2011 | WO2011029886A1 Implantable sensor |
| 03/17/2011 | WO2011029869A1 Hypoallergenic hybrid polypeptides for the treatment of allergy |
| 03/17/2011 | WO2011029794A1 Multiplexed analyte concentration measurement |
| 03/17/2011 | WO2011029661A1 Probe plug for exhaust gas probes |
| 03/17/2011 | WO2011029607A1 S. aureus allergen |
| 03/17/2011 | WO2011029601A1 Method and device for determining clotting time |
| 03/17/2011 | WO2011029600A1 Method for determining thrombocyte functions by means of a resonator |
| 03/17/2011 | WO2011029593A1 Device for testing for hemostasis |
| 03/17/2011 | WO2011029584A1 Spontaneously contracting fish cell aggregates, use thereof and method for the production thereof |
| 03/17/2011 | WO2011029567A1 Storage containers for test elements |
| 03/17/2011 | WO2011029459A1 Novel photoactivable fluorescent dyes for optical microscopy and image techniques |
| 03/17/2011 | WO2011029201A1 Methods and kits for the detection of heart disease |
| 03/17/2011 | WO2011029193A1 Method of treating cancer by inhibiting trim59 expression or activity |
| 03/17/2011 | WO2011029126A1 Methods and reagents for producing antibodies against autoantigens |